PDB Short entry for 2ZV2 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 31-OCT-08 2ZV2 TITLE CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TITLE 2 KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE BETA, COMPND 6 CAM-KINASE KINASE BETA, CAM-KK BETA, CAMKK BETA; COMPND 7 EC: 2.7.11.17; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CELL FREE PROTEIN SYNTHESIS; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PX070406-05 KEYWDS CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, STO-609, KEYWDS 2 CAMKK2, E.C.2.7.11.17, PHOSPHORYLATION, AMPKK, METABOLISM, ATP- KEYWDS 3 BINDING, KINASE, CALMODULIN-BINDING, NUCLEOTIDE-BINDING, KEYWDS 4 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, KEYWDS 5 STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL KEYWDS 6 AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 7 INITIATIVE, RSGI, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.YOSHIKAWA,M.KUKIMOTO-NIINO,M.SHIROUZU,A.SUZUKI,S.LEE,Y.MINOKOSHI, AUTHOR 2 S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 01-NOV-23 2ZV2 1 REMARK SEQADV REVDAT 3 20-NOV-13 2ZV2 1 JRNL VERSN REVDAT 2 11-MAY-11 2ZV2 1 HEADER JRNL REVDAT 1 03-NOV-09 2ZV2 0 JRNL AUTH M.KUKIMOTO-NIINO,S.YOSHIKAWA,T.TAKAGI,N.OHSAWA,Y.TOMABECHI, JRNL AUTH 2 T.TERADA,M.SHIROUZU,A.SUZUKI,S.LEE,T.YAMAUCHI,M.OKADA-IWABU, JRNL AUTH 3 M.IWABU,T.KADOWAKI,Y.MINOKOSHI,S.YOKOYAMA JRNL TITL CRYSTAL STRUCTURE OF THE CA2+/CALMODULIN-DEPENDENT PROTEIN JRNL TITL 2 KINASE KINASE IN COMPLEX WITH THE INHIBITOR STO-609 JRNL REF J.BIOL.CHEM. V. 286 22570 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21504895 JRNL DOI 10.1074/JBC.M111.251710 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 172431.500 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 16795 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 858 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2432 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE : 0.2670 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 118 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2066 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.03000 REMARK 3 B22 (A**2) : -1.61000 REMARK 3 B33 (A**2) : -0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.590 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.110 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.480 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.840 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 48.80 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : STO.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : STO_609.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ZV2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000028461. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17475 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 56.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.490 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.60700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.770 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2VN9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM CACODYLATE (PH 5.9), 0.2M REMARK 280 SODIUM ACETATE TRIHYDRATE, 18% PEG 8000, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.68400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.16600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.57650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.16600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.68400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.57650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 152 REMARK 465 SER A 153 REMARK 465 SER A 154 REMARK 465 GLY A 155 REMARK 465 SER A 156 REMARK 465 SER A 157 REMARK 465 GLY A 158 REMARK 465 ASP A 159 REMARK 465 CYS A 160 REMARK 465 GLY A 175 REMARK 465 SER A 176 REMARK 465 LYS A 201 REMARK 465 LEU A 202 REMARK 465 ILE A 203 REMARK 465 ARG A 204 REMARK 465 GLN A 205 REMARK 465 ALA A 206 REMARK 465 GLY A 207 REMARK 465 PHE A 208 REMARK 465 PRO A 209 REMARK 465 ARG A 210 REMARK 465 ARG A 211 REMARK 465 PRO A 212 REMARK 465 PRO A 213 REMARK 465 PRO A 214 REMARK 465 ARG A 215 REMARK 465 GLY A 216 REMARK 465 THR A 217 REMARK 465 ARG A 218 REMARK 465 PRO A 219 REMARK 465 ALA A 220 REMARK 465 PRO A 221 REMARK 465 GLY A 222 REMARK 465 GLY A 223 REMARK 465 CYS A 224 REMARK 465 ILE A 225 REMARK 465 GLN A 226 REMARK 465 PRO A 227 REMARK 465 ARG A 228 REMARK 465 GLY A 229 REMARK 465 PRO A 230 REMARK 465 ILE A 231 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 164 -115.88 62.78 REMARK 500 LYS A 169 -152.94 -123.01 REMARK 500 ASN A 187 7.97 55.11 REMARK 500 ASP A 188 -30.41 -144.94 REMARK 500 LYS A 199 77.66 -57.76 REMARK 500 VAL A 271 79.32 -110.42 REMARK 500 LYS A 283 76.53 -115.96 REMARK 500 PRO A 284 -178.50 -61.96 REMARK 500 ARG A 312 -4.68 70.26 REMARK 500 ASP A 313 41.99 -142.57 REMARK 500 ASP A 331 77.13 59.26 REMARK 500 ASP A 393 130.36 173.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 609 A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK002300769.1 RELATED DB: TARGETDB DBREF 2ZV2 A 159 449 UNP Q96RR4 KKCC2_HUMAN 158 448 SEQADV 2ZV2 GLY A 152 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 SER A 153 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 SER A 154 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 GLY A 155 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 SER A 156 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 SER A 157 UNP Q96RR4 EXPRESSION TAG SEQADV 2ZV2 GLY A 158 UNP Q96RR4 EXPRESSION TAG SEQRES 1 A 298 GLY SER SER GLY SER SER GLY ASP CYS VAL GLN LEU ASN SEQRES 2 A 298 GLN TYR THR LEU LYS ASP GLU ILE GLY LYS GLY SER TYR SEQRES 3 A 298 GLY VAL VAL LYS LEU ALA TYR ASN GLU ASN ASP ASN THR SEQRES 4 A 298 TYR TYR ALA MET LYS VAL LEU SER LYS LYS LYS LEU ILE SEQRES 5 A 298 ARG GLN ALA GLY PHE PRO ARG ARG PRO PRO PRO ARG GLY SEQRES 6 A 298 THR ARG PRO ALA PRO GLY GLY CYS ILE GLN PRO ARG GLY SEQRES 7 A 298 PRO ILE GLU GLN VAL TYR GLN GLU ILE ALA ILE LEU LYS SEQRES 8 A 298 LYS LEU ASP HIS PRO ASN VAL VAL LYS LEU VAL GLU VAL SEQRES 9 A 298 LEU ASP ASP PRO ASN GLU ASP HIS LEU TYR MET VAL PHE SEQRES 10 A 298 GLU LEU VAL ASN GLN GLY PRO VAL MET GLU VAL PRO THR SEQRES 11 A 298 LEU LYS PRO LEU SER GLU ASP GLN ALA ARG PHE TYR PHE SEQRES 12 A 298 GLN ASP LEU ILE LYS GLY ILE GLU TYR LEU HIS TYR GLN SEQRES 13 A 298 LYS ILE ILE HIS ARG ASP ILE LYS PRO SER ASN LEU LEU SEQRES 14 A 298 VAL GLY GLU ASP GLY HIS ILE LYS ILE ALA ASP PHE GLY SEQRES 15 A 298 VAL SER ASN GLU PHE LYS GLY SER ASP ALA LEU LEU SER SEQRES 16 A 298 ASN THR VAL GLY THR PRO ALA PHE MET ALA PRO GLU SER SEQRES 17 A 298 LEU SER GLU THR ARG LYS ILE PHE SER GLY LYS ALA LEU SEQRES 18 A 298 ASP VAL TRP ALA MET GLY VAL THR LEU TYR CYS PHE VAL SEQRES 19 A 298 PHE GLY GLN CYS PRO PHE MET ASP GLU ARG ILE MET CYS SEQRES 20 A 298 LEU HIS SER LYS ILE LYS SER GLN ALA LEU GLU PHE PRO SEQRES 21 A 298 ASP GLN PRO ASP ILE ALA GLU ASP LEU LYS ASP LEU ILE SEQRES 22 A 298 THR ARG MET LEU ASP LYS ASN PRO GLU SER ARG ILE VAL SEQRES 23 A 298 VAL PRO GLU ILE LYS LEU HIS PRO TRP VAL THR ARG HET 609 A 501 24 HETNAM 609 7-OXO-7H-BENZIMIDAZO[2,1-A]BENZ[DE]ISOQUINOLINE-3- HETNAM 2 609 CARBOXYLIC ACID FORMUL 2 609 C19 H10 N2 O3 FORMUL 3 HOH *53(H2 O) HELIX 1 1 GLU A 232 LYS A 243 1 12 HELIX 2 2 SER A 286 GLN A 307 1 22 HELIX 3 3 LYS A 315 SER A 317 5 3 HELIX 4 4 THR A 351 MET A 355 5 5 HELIX 5 5 ALA A 356 LEU A 360 5 5 HELIX 6 6 GLY A 369 GLY A 387 1 19 HELIX 7 7 ARG A 395 GLN A 406 1 12 HELIX 8 8 ALA A 417 LEU A 428 1 12 HELIX 9 9 VAL A 437 LYS A 442 1 6 HELIX 10 10 HIS A 444 ARG A 449 1 6 SHEET 1 A 6 GLN A 162 LEU A 163 0 SHEET 2 A 6 TYR A 166 GLY A 173 -1 O TYR A 166 N LEU A 163 SHEET 3 A 6 VAL A 179 ASN A 185 -1 O TYR A 184 N THR A 167 SHEET 4 A 6 THR A 190 SER A 198 -1 O MET A 194 N LYS A 181 SHEET 5 A 6 HIS A 263 GLU A 269 -1 O MET A 266 N LYS A 195 SHEET 6 A 6 LEU A 252 ASP A 257 -1 N VAL A 253 O VAL A 267 SHEET 1 B 2 ILE A 309 ILE A 310 0 SHEET 2 B 2 ASN A 336 GLU A 337 -1 O ASN A 336 N ILE A 310 SHEET 1 C 2 LEU A 319 VAL A 321 0 SHEET 2 C 2 ILE A 327 ILE A 329 -1 O LYS A 328 N LEU A 320 SHEET 1 D 2 LEU A 344 LEU A 345 0 SHEET 2 D 2 PHE A 367 SER A 368 -1 O PHE A 367 N LEU A 345 CISPEP 1 VAL A 279 PRO A 280 0 0.06 CISPEP 2 GLN A 413 PRO A 414 0 -0.04 SITE 1 AC1 12 HOH A 28 ILE A 172 ALA A 193 LYS A 195 SITE 2 AC1 12 PHE A 268 GLU A 269 LEU A 270 VAL A 271 SITE 3 AC1 12 ASN A 272 GLY A 274 LEU A 320 ASP A 331 CRYST1 67.368 77.153 84.332 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014844 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012961 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011858 0.00000